Acridine derivatives: a patent review (2009 –– 2010)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.4, 2011-04, pp. : 437-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acridine and its derivatives: a patent review (2009 – 2013)

By Zhang Bin Li Xi Li Bin Gao Chunmei Jiang Yuyang

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 647-664

Informa Healthcare

Access to resources Recommend Favorite

Checkpoint kinase inhibitors: a patent review (2009 –– 2010)

By Lainchbury Michael Collins Ian

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1191-1210

Informa Healthcare

Access to resources Recommend Favorite

Resveratrol derivatives: a patent review (2009 – 2012)

By Pezzuto John M Kondratyuk Tamara P Ogas Talysa

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1529-1546

Informa Healthcare

Access to resources Recommend Favorite

Berberine and its derivatives: a patent review (2009 – 2012)

By Singh Inder Pal Mahajan Shivani

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 215-231

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase-2 inhibitors: a literature and patent review (2009 – 2010)

By Jawabrah Al-Hourani Baker Sharma Sai Kiran Suresh Mavanur Wuest Frank

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1339-1432

Informa Healthcare

Access to resources Recommend Favorite